One Pill Panacea?

September 9, 2014 9:35 PM

6 0

WASHINGTON -- Will fixed-dose polypills safely and effectively reduce the risk of heart attack and stroke as well as individual doses of the same medications? That is the question that the FDA addresses this week in back-to-back advisory committee reviews of two investigational polypills.

Today the FDA's Cardiovascular and Renal Drugs Advisory Committee will review a combination of beta-blocker and angiotensin receptor blocker -- nebivolol/valsartan -- and tomorrow that same committee will review the merits of using a pill combination containing an antihypertensive, aspirin, and a st...

Read more

To category page